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Monoamines are implicated in the modulation of adult hippocampal neurogenesis in depression mod-
els and following chronic antidepressant treatment. Given the key role of Sonic hedgehog (Shh) in adult
neurogenesis, we examined whether monoaminergic perturbations regulate the expression of Shh or
its co-receptors Smoothened (Smo) and Patched (Ptc). Combined depletion of both serotonin and nore-
pinephrinewith para-chlorophenylalanine (PCPA) resulted in a signiﬁcant decrease in Smo and PtcmRNA
within the dentate gyrus subﬁeld of the hippocampus. However, selective depletion of serotonin, using
the serotonergic neurotoxin 5,7-dihyrdroxytryptamine (5,7-DHT), or norepinephrine, using the nora-orepinephrine
-Chlorophenylalanine
-Chloroamphetamine
,7-Dihydroxytryptamine
SP-4
luoxetine
esipramine
drenergic neurotoxin DSP-4, did not alter expression of Shh and its co-receptors, Smo and Ptc. Acute
treatment with the monoamine releasing agent, para-chloroamphetamine (PCA) signiﬁcantly upregu-
lated Smo mRNA within the dentate gyrus. However, acute or chronic treatment with pharmacological
antidepressants that modulate monoaminergic neurotransmission did not regulate Shh cascade expres-
sion. These results indicate that robust changes in monoamine levels can regulate the expression of the
the ad
ranylcypromine
Shh signaling cascade in
nimal models of depression exhibit decreased adult hip-
ocampal neurogenesis [19,27], whereas sustained antidepressant
dministration increases hippocampal neurogenesis [18] and
s thought to contribute to the behavioral effects of antide-
ressants [23]. The monoaminergic hypothesis suggests that
ecreased monoamines underlie the pathogenesis of depression,
nd increased monoamines contribute to antidepressant action
6]. Recently monoaminergic neurotransmission has been impli-
ated in the effects of depression models and antidepressants
n adult hippocampal neurogenesis [23,26]. A decline in hip-
ocampal neurogenesis is observed following serotonin (5-HT)
nd/or norepinephrine (NE) depletion, while increased hippocam-
al neurogenesis is seen following elevation of monoamine levels
4,9,12,18]. However, the pathways that underlie the effects of
onoamines on adult hippocampal neurogenesis are not under-
tood.
Sonic hedgehog (Shh) is a powerful regulator of adult hippocam-
al neurogenesis and is essential for the maintenance of the adult
tem cell niches [14,17,21]. In the adult brain, Shh is expressed in
he neocortex and the horizontal and vertical limbs of the diagonal
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band from where it is thought to be anterogradely transported to
the hippocampus [24,25]. Within the hippocampus, expression of
theShhco-receptorsPatched (Ptc) andSmoothened (Smo) is seen in
the dentate gyrus subﬁeld including the neurogenic niche of sub-
granular zone (SGZ) [14,24]. Smo protein has also been recently
shown to localize predominantly to mossy ﬁber nerve terminals in
the hippocampus [20]. Recent evidence indicates that the neuro-
genic effects of electroconvulsive seizure (ECS) treatment, one of
the most robust forms of antidepressant therapy, requires Shh sig-
naling and ECS also regulates the hippocampal expression of Smo
and Ptc [1]. We hypothesized that monoaminergic neurotransmis-
sionmay inﬂuence the expressionof the Shh cascade. The aimof the
present study was to address whether robust perturbations in the
levels of 5-HT and NE or treatment with pharmacological antide-
pressants regulate the expression of key components of the Shh
signaling cascade.
Male Sprague–Dawley rats (200–250g; TIFR animal breeding
colony) were group-housed and maintained on a controlled 12h
light/dark cycle with access to food andwater ad libitum. All animal
procedures were carried out in accordance with the NIH Guide for
the Care and Use of Laboratory Animals, and were approved by the
TIFR Institutional Animal Ethics Committee.
To induce a combined depletion of norepinephrine (NE) and
serotonin (5-HT), animalswere treatedwithp-chlorophenylalanine
(PCPA, 300mg/kg—2 days, 100mg/kg—2 days; Sigma, USA) as
ience
p
o
b
a
o
(
d
r
a
p
m
m
v
w
a
t
v
a
(
(
s
p
a
d
A
a
o
d
u
M
b
b
w
2
i
t
m
I
f
e
(
t
d
t
b
a
o
s
w
a
u
m
s
r
p
(
H
e
q
B
s
a
c
fR. Rajendran et al. / Neurosc
reviously described [4,9]. To induce a selective depletion
f NE, animals were treated with N-Ethyl-N-(2-chloroethyl)-2-
romobenzylamine hydrochloride (DSP-4, 10mg/kg, Sigma) using
previously described protocol [12]. To induce a selective depletion
f 5-HT, animals received an intracerebroventricular (i.c.v.) infusion
AP-0.8mm, ML-1.4mm and DV-4.0mm from Bregma [22]) of 5,7-
ihydroxytryptamine (5,7-DHT,200g/animal, 20g/l, Sigma)as
eported previously [9]. The choice of dose, treatment paradigm
nd time-point for sacriﬁce for the above studies was based on
rior literature that indicated a robust depletion of the speciﬁc
onoamines [4,9,12]. To induce a robust monoamine release, ani-
als received p-Chloroamphetamine (PCA, 10mg/kg, Sigma) or
ehicle (0.9% saline) through intraperitoneal (i.p.) injection and
ere sacriﬁced 2h later. For the acute antidepressant experiment,
nimals received an i.p. injection of ﬂuoxetine (FLX; 5mg/kg),
ranylcypromine (TCP; 7.5mg/kg), desipramine (DMI; 15mg/kg) or
ehicle (0.9% saline) and were sacriﬁced 2h later. For the chronic
ntidepressant experiment, animals received i.p. injections of FLX
5mg/kg), TCP (7.5mg/kg for 7 days and 10mg/kg for 14 days), DMI
15mg/kg) or vehicle (0.9 % saline) once daily for 21 days and were
acriﬁced2hafter the last treatment. The choiceof doses for antide-
ressant treatments was based on prior literature that indicated
n effect on adult hippocampal progenitor proliferation at these
oses [18]. All antidepressant drugs were obtained from Sigma.
fter decapitation, brains were frozen prior to cryostat sectioning
nd in situ hybridization analysis.
In situ hybridization was carried out as previously described [1]
n 14m thick coronal sections. Slides were ﬁxed, acetylated and
ehydrated. Rat Shh, Smo and Ptc cRNA probes were transcribed
sing 35S-labeled UTP (Amersham) from plasmids provided by Dr.
artial Ruat (CNRS, France). Slides were incubated with radiola-
eled riboprobes (1×106 cpm/150l per slide) in hybridization
uffer overnight and then subjected to stringent post-hybridization
ashes. Slides were exposed to Hyperﬁlm -max (Amersham) for
–3 weeks. Shh, Ptc or Smo sense riboprobes did not yield signif-
cant hybridization (data not shown) conﬁrming the speciﬁcity of
he signal observedwith the antisense riboprobes. Shh, Ptc andSmo
RNA levels were quantitated with the Macintosh-based Scion
mage software (Scion, USA) using 14C standards (Amersham, USA)
or calibration and to correct for non-linearity. For Shh mRNA,
xpression in the horizontal and vertical limbs of the diagonal band
VDB) and in theneocortexwasquantitated. For Ptc andSmomRNA,
he expression in the dentate gyrus was determined. The optical
ensitywas determinedby outlining an equivalent area in each sec-
ion, and themeanswere determined frommeasurements taken on
oth sides of 4 individual sections/animal.
Quantitative real-time PCR (qPCR) was also performed for
cute PCA treatment. Animals (n=5/group) were treated with PCA
r vehicle and sacriﬁced as described earlier. Hippocampi were
ubdissected in cold saline and frozen in liquid nitrogen. Total RNA
as isolated from hippocampal tissue using Tri Reagent (Sigma),
ccording to the manufacturer’s protocol. RNA was quantiﬁed
sing Nanodrop (Eppendorf, Germany) and RNA quality deter-
ined by resolving on 1% formaldehyde agarose gel. cDNA was
ynthesized from 200ng of total RNA per sample using Quantitect
everse transcription kit (Qiagen, USA), as per the manufacturer’s
rotocol. cDNAwas ampliﬁed and visualized using a SYBRGreen kit
Applied Biosystems, USA) in a Realplex mastercycler (Eppendorf).
ypoxanthine phopshoribosyl transferase (HPRT) was used as the
ndogenous control. To compare HPRT and target gene, relative
uantiﬁcation was performed using comparative CT method [2].
rieﬂy, this comparative CT method involved averaging duplicate
amples of each target and endogenous control in both control
nd treatment samples [i.e. CT = absolute CT value− endogenous
ontrol CT value and CT =CT treatment− CT control]. The
old change was calculated according to the formula 2(−CT). TheLetters 453 (2009) 190–194 191
primer sequences used were Ptc F—CCATTTCTTGCCCTTGGTGTT-
GGT, R—AATGCAGCCATGAAGAAGGCAGTG; Smo F—AATTGGCCTG-
GTGCTTATTGTGGG, R—AGGGTGGTTGCTCTTGATGGAGAA; HPRT
F—GCAGACTTTGCTTTCCTTGG, R—GTCTGGCCTGTATCCAACACT.
Experiments were analyzed for differences using the unpaired
Student’s t-test (Prism, Graphpad, USA) with signiﬁcance deter-
mined at p values <0.05.
Combined, but not selective, depletion of norepinephrine and
serotonin levels downregulates Smo and Ptc mRNA levels in the
dentate gyrus.
The expression of Smo, the signaling component of the Shh
receptor complex, was found to be signiﬁcantly decreased (∼30%)
in the hippocampal dentate gyrus subﬁeld following depletion of
both NE and 5-HT by PCPA treatment. In addition, there was a
small but signiﬁcant decrease (∼20%) in the level of Ptc mRNA in
the DG of PCPA treated animals as compared to the vehicle group
(Fig. 1). In striking contrast, selective noradrenergic (DSP-4) and
serotonergic (5,7-DHT) neurotoxin treatments did not alter Smo
or Ptc mRNA expression in the hippocampus (Fig. 2). The mRNA
expression of the ligand Shh in the VDB (Figs. 1 and 2) and the
neocortex (PCPA treatment: Veh=100±3.27, PCPA=98.83±2.09;
DSP-4 treatment: Veh=100±11.47, DSP-4=99.75±7.22; 5,7-DHT
treatment: Veh=100±5.82, 5,7-DHT=113.09±4.29; results are
expressed as percent of Vehicle and are the mean± S.E.M.) was
not inﬂuenced by PCPA, DSP-4 or 5,7-DHT treatments. As previ-
ously reported [24], Shh mRNA expression was high in the VDB
and was expressed at relatively lower levels in the neocortex
(layer V).
Treatment with the monoamine releasing agent, PCA, increases
Smo mRNA in the dentate gyrus, however pharmacological
antidepressants do not regulate the Shh signaling cascade.
Acute PCA treatment resulted in a robust and signiﬁcant
upregulation of Smo mRNA (∼65%) within the DG subﬁeld
of the hippocampus (Fig. 1). PCA treatment did not inﬂuence
either the expression of Shh in the basal forebrain (Fig. 1) or
neocortex (PCA Treatment, Shh mRNA levels: Veh=100±8.26,
PCA=113.35±11.25, results are expressed as percent of Vehicle
and are the mean± S.E.M.) or the co-receptor Ptc in the hippocam-
pal subﬁelds (Fig. 1). The in situ regulation of Smo and Ptc mRNA
were further validated by qPCR for acute PCA treatment. Acute PCA
resulted ina70% increase inSmomRNAin thehippocampusas com-
pared to vehicle treated controls (CT acute PCA=0.915±0.1762;
CT Vehicle =1.68±0.2463; CT =−0.765; results are expressed
as CT and are the mean± S.E.M.; p<0.05, Student’s t-test). Hip-
pocampal Ptc mRNA levels were found to be unaltered following
acute PCA treatment (CT acute PCA=3.041±0.3414; CT Vehi-
cle =3.577±0.2124; CT =−0.536; results are expressed as CT
and are the mean± S.E.M.; p>0.05, Student’s t-test). Further, Shh
mRNA levels in the VDB and the neocortex, and Smo and Ptc mRNA
levels in the DG were not altered by either acute or chronic treat-
ment with the pharmacological antidepressants DMI, FLX or TCP
(Table 1).
The present study indicates that robust changes in levels of both
5-HT and NEmodulate the expression of the Shh co-receptors, Smo
andPtc, in thehippocampal dentate gyrus subﬁeld.While depletion
of both 5-HT and NE (PCPA) decreased Smo and Ptc hippocam-
pal mRNA levels, selective depletion of either 5-HT (5,7-DHT) or
NE (DSP-4) did not alter their expression. Further, acute treatment
with the monoamine releasing agent PCA signiﬁcantly increased
SmomRNA levels. In contrast, acuteor chronic antidepressant treat-
mentwith the serotonin selective reuptake inhibitor, ﬂuoxetine, the
norepinephrine selective reuptake inhibitor, desipramine, and the
monoamine oxidase inhibitor, tranylcyprominedid not regulate the
expression of the Shh cascade. Our study provides novel evidence
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Fig. 1. Inﬂuence of PCPA & PCA treatment on the expression of the Shh cascade in the adult rat brain. Rats were administered either PCPA, PCA or vehicle (VEH) treatment in
separate experiments, and levels of Shh, Smo and PtcmRNAwere determined by in situ hybridization and quantitative densitometry. PCPA treatment decreased the expression
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epresentative autoradiographs of Shh, Smo and Ptc mRNA from vehicle and PCPA
hown. Results are expressed as percent of vehicle and are the mean ±S.E.M. (n=5 /
f an inﬂuence of NE and 5-HT on the expression of the Shh signal-
ng cascade, a major developmental pathway that continues to be
xpressed in the adult brain.
The effects of Shh have been best studied during development,
here it regulates the proliferation, survival and fate determination
f embryonic neuronal and glial precursors [7]. Recently Shh signal-
ng has been shown to play a critical role in maintaining stem cell
iches in the adult brain [17], where it regulates adult progenitor
roliferation [14,21]. These studies suggest that the Shh pathway
ay continue to have an important role in adulthood in regulat-
ng structural plasticity. Given prior evidence that monoamines
egulate the proliferation and survival of hippocampal progeni-
ors [4,9,10,12,16], our results raise the possibility that the effects
f monoaminergic neurotransmission on the expression of the Shh
ignaling cascade could contribute to the inﬂuence of monoamines
n adult neurogenesis.
In this regard, it is particularly interesting to note that selec-ive depletion of NE (DSP-4) or 5-HT (5,7-DHT) does not alter
xpression of the Shh cascadewhereas combined depletion of both
onoamines (PCPA) results in a signiﬁcant decline in hippocam-
al Smo and PtcmRNA levels. While DSP-4 and 5,7-DHT selectively
nduce a decrease in the proliferation of hippocampal progenitorsion in the Horizontal limb/Vertical limb of the Diagonal Band (VDB)—Upper Panel.
er the levels of Ptc mRNA in the DG or Shh in the VDB/HDB region—Lower Panel.
ed animals (Upper Panel) and vehicle and PCA treated animals (Lower Panel) are
); *p<0.05 as compared with vehicle (Student’s t-test).
[4,12], PCPA has a more dramatic effect on hippocampal neurogen-
esis resulting in robust decreases in both proliferation and survival
of adult hippocampal progenitors [9]. It is possible to speculate a
role for reduced Shh signaling in mediating the robust decline in
neurogenesis following PCPA administration. Strikingly, treatment
with PCA, which would increase the levels of both NE and 5-HT
[11], resulted in a signiﬁcant increase in the expression of Smo
mRNA.We did not observe any regulation of ShhmRNA expression
by either PCPA or PCA suggesting the possibility that monoamine
neurotransmission may modulate expression of receptors for Shh
directly rather than via an effect on the ligand. Future studies are
required for a clear understanding of the role of the Shh cascade
in mediating the effects of monoaminergic perturbations on adult
hippocampal neurogenesis.
It is intriguing that ECS and PCA differ in their effects on hip-
pocampal SmomRNA expression, as ECS would also be expected to
enhancemonoamine levelswithin the hippocampus [8]. Given that
ECS induces the release of several other neurotransmitters besides
monoamines [5,15], it points to the possibility that other neuro-
transmitters pathways andneuronal activitymay induce a different
effect on Smo mRNA expression than that observed with selective
monoamine release induced by acute PCA treatment.
R. Rajendran et al. / Neuroscience Letters 453 (2009) 190–194 193
Fig. 2. Inﬂuence of DSP-4 and 5,7-DHT treatment on the expression of the Shh cascade in the rat brain. Rats received treatment with vehicle (VEH), DSP-4 or 5,7-DHT in
s in situ
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weparate experiments, and levels of Shh, Smo and Ptc mRNA were determined with
nﬂuence Shh mRNA expression in the Horizontal limb/Vertical limb of the Diagon
entate gyrus (DG) subﬁeld. Representative autoradiographs of Shh, Smo and PtcmR
nimals are shown. Results are expressed as percent of vehicle and are the mean ±SAt present the mechanism by which NE and 5-HT may inﬂu-
nce expression of the Shh signaling cascade is unclear. However,
he cAMP-Protein kinase A (PKA) pathway, is an attractive candi-
ate. Activation of the cAMP cascade by the adrenoceptor agonist
soproterenol enhances Ptc expression in the pineal gland [3]. It is
able 1
cute or chronic treatment with different classes of antidepressants does not inﬂuence th
Shh mRNA (Neocortex)
cute antidepressant treatment
VEH 100±13.45
Ac DMI 108.03±1.31
VEH 100±4.08
Ac FLX 100.88±1.7
VEH 100±3.1
Ac TCP 91.1±0.87
hronic antidepressant treatment
VEH 100±10.27
Chr DMI 72.15±8.55
VEH 100±6.18
Chr FLX 91.36±8.82
VEH 100±6.18
Chr TCP 92.3±9.16
nimals were administered Desipramine (DMI), Fluoxetine (FLX) or Tranylcypromine (TC
evels of Shh, Smo and Ptc were studied using in situ hybridization and analyzed by quant
ere unaltered after either acute or chronic treatment byDMI, FLX or TCP. Smo and PtcmR
ith these agents. Results are expressed as percent of vehicle and are the mean ±S.E.M. (hybridization and quantitative densitometry. DSP-4 or 5,7-DHT treatment did not
d (VDB) or the expression of the Shh receptors, Smo and Ptc in the hippocampal
m vehicle and DSP-4 (Upper Panel), and vehicle and 5,7-DHT (Lower Panel) treated
(n=5/group).possible to speculate that thedecreasedSmoandPtc expression fol-
lowing robust monoamine depletion may involve decreased cAMP
cascade activation. Taken together, these studies raise the possibil-
ity thatmonoaminergic signaling canmodulate thegeneexpression
of the Shh pathway in adulthood. Given that Shh plays a critical
e mRNA expression of the Shh cascade.
Shh mRNA (VDB/HDB) Ptc mRNA (DG) Smo mRNA (DG)
100±15.44 100±4.94 100±11.42
98.66±7.04 110.9±7.43 93.88±12.89
100±13.34 100±5.81 100±4.67
96.66±3.09 92.92±2.17 90.74±25.84
100±13.34 100±4.94 100±12.6
89.06±5.92 93.16±5.14 86.58±2.17
100±12.61 100±8.5 100±10.1
81.68±9.67 112.46±5.82 91.56±10.6
100±13.55 100±7.36 100±3.94
80.32±2.5 97.44±4.59 115.35±16.4
100±13.55 100±7.38 100±11.25
77.99±9.78 113.40±0.58 78.38±10.66
P) either as a single dose (acute) or once daily for 21 days (chronic), and the mRNA
itative densitometry. Shh mRNA levels in the HDB/VDB region and in the neocortex
NA levels in the hippocampal DGwere also unaffected by acute or chronic treatment
n=4–5/group).
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ole during development, further studies to explore the effects of
onoaminergic perturbation during gestation on fetal Shh signal-
ng and consequences on brain development are warranted.
Unlikeprevious results [1] that indicate a signiﬁcant effect of ECS
reatment on hippocampal Smo and Ptc expression and a role for
hh signaling in the neurogenic effects of ECS, the present study
ndicates that acute or chronic pharmacological antidepressant
reatments do not regulate Shh cascade expression. Interestingly,
CA, which robustly enhances monoamine levels, did upregulate
momRNA expression, however pharmacological antidepressants,
hich also elevate synaptic monoamine levels did not appear to do
o. This discrepancy in the regulation of Smo mRNA may be a con-
equence of the extent of elevation in monoamine levels observed
ith amonoamine releasing agent [13,28] in contrast to the change
een with agents that block reuptake or degradation. This points
o the possibility that modulation of the hippocampal expression
f the Shh cascade may require very robust changes in both 5-
T and NE. This is supported by evidence that ECS, PCA and PCPA
reatments can regulate Ptc and Smo expression, whereas selec-
ive depletions of 5-HT or NE and treatment with pharmacological
ntidepressants does not regulate the Shh cascade expression.
In conclusion, our results provide novel evidence that
onoaminergic neurotransmission modulates the Shh signaling
ascade expression in the adultmammalianbrain, andhighlight the
eed for future studies to understand the mechanism of this reg-
lation and the role of Shh signaling in the effects of monoamines
n adult structural plasticity.
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